Congrats to the Subtle team!
We have some very exciting news to announce today! Our AI-powered synthetic imaging software, SubtleSYNTH™, has received FDA clearance and is now available for clinical use in the US! 🚀 SubtleSYNTH™ uses deep learning to generate synthetic STIR images from already-acquired T1 and T2 weighted contrasts, creating STIR images with zero acquisition time that are interchangeable with conventionally acquired STIR images. This is an industry first, and we thank all of the members on the @SubtleMedical team and the clinical partners who helped us reach this milestone. This is just the start, as we explore plans to expand to Brain and MSK imaging next. Read the full press release below, and be sure to join us at RSNA this year to learn more about how SubtleSYNTH™ and our suite of imaging solutions can redefine your MRI imaging program. https://lnkd.in/g6Hr7uGC #AI #HealthcareInnovation #MedicalImaging #FDAcleared #SubtleSYNTH #SubtleMedical #MRI #Radiology #RSNA2023 #HealthcareTransformation